Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $51.96 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $33.04 | 2 | $0 (2023) |
| Genentech USA, Inc. | $18.92 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $33.04 | 2 | Abbott Laboratories ($33.04) |
| 2021 | $18.92 | 4 | Genentech USA, Inc. ($18.92) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes Care | ||||||
| 02/09/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes Care | ||||||
| 11/17/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Virology & Specialty Care | ||||||
| 11/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Virology & Specialty Care | ||||||
| 11/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Virology & Specialty Care | ||||||
| 11/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 15 | 15 | $1,200 | $529.95 |
| 2021 | 9 | 346 | 505 | $54,577 | $15,125 |
| 2020 | 6 | 133 | 133 | $23,051 | $6,327 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 15 | $1,200 | $529.95 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 122 | $27,430 | $6,663 | 24.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $10,560 | $2,964 | 28.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 81 | 83 | $6,640 | $2,932 | 44.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $4,320 | $1,704 | 39.4% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 15 | 30 | $1,500 | $496.50 | 33.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 28 | $1,120 | $162.00 | 14.5% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 11 | 11 | $737.00 | $124.93 | 17.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 27 | 29 | $870.00 | $65.25 | 7.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 14 | 140 | $1,400 | $13.25 | 0.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 35 | 35 | $6,300 | $1,498 | 23.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 23 | $5,520 | $1,360 | 24.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $3,840 | $1,177 | 30.6% |
| 87426 | Coronavirus ag ia | Office | 2020 | 30 | 30 | $2,400 | $1,060 | 44.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 15 | $3,115 | $873.78 | 28.1% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 14 | 14 | $1,876 | $358.81 | 19.1% |
About Lindsey Hull, FNP-BC
Lindsey Hull, FNP-BC is a Family healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1922344407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsey Hull, FNP-BC has received a total of $51.96 in payments from pharmaceutical and medical device companies, with $33.04 received in 2023. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($51.96).
As a Medicare-enrolled provider, Hull has provided services to 494 Medicare beneficiaries, totaling 653 services with total Medicare billing of $21,982. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family, Family
- Location Woonsocket, RI
- Active Since 01/02/2013
- Last Updated 03/06/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1922344407
Products in Payments
- FREESTYLE LIBRE 3 (Device) $33.04
- Xofluza (Drug) $18.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Woonsocket
Mrs. Karin O'rourke, Rnp, RNP
Family — Payments: $3,773
Geraldine Cole, Crnp, CRNP
Family — Payments: $1,895
Jessica Lawler, Np, NP
Family — Payments: $1,688
Audette Johnson
Family — Payments: $474.17
Jennifer Hopgood, Fnp-Bc, FNP-BC
Family — Payments: $442.83
Mia Tait, Fnp-C, FNP-C
Family — Payments: $315.83